WARREN, N.J. (AP) _ Aquestive Therapeutics Inc. (AQST) on Thursday reported a loss of $13.9 million in its fourth quarter.
On a per-share basis, the Warren, New Jersey-based company said it had a loss of 56 cents.
The specialty pharmaceutical company posted revenue of $16.8 million in the period.
For the year, the company reported a loss of $61.4 million, or $2.96 per share. Revenue was reported as $67.4 million.
Aquestive Therapeutics expects full-year revenue in the range of $33 million to $45 million.
Aquestive Therapeutics shares have risen 20 percent since the beginning of the year.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AQST at https://www.zacks.com/ap/AQST